(1997) Pathophysiology of primary pulmonary hypertension, New York, NY: Marcel Dekker

(2002) Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension,

(1999) Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers.Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth,

(2001) Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension,

(2003) Inflammation in pulmonary arterial hypertension,

(2002) CX(3)C chemokine fractalkine in pulmonary arterial hypertension,

(2001) Pathobiology of pulmonary hypertension.The role of platelets and thrombosis,

(1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension,

(1999) Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension,

(1995) Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension,

(2003) Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension,

(2003) Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension,

(1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension,

(1998) Attenuated K+ channel gene transcription in primary pulmonary hypertension,

(2002) Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels,

(1996) Anorexic agents aminorex,fenfluramine,and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction,

(1995) Increased plasma serotonin in primary pulmonary hypertension,

(1997) Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats,

(2000) Controlling TGF-beta signaling,

(2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus,

(2000) Familial primary pulmonary hypertension(gene PPH1)is caused by mutations in the bone morphogenetic protein receptor-II gene,

(2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium,

(2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family,

(2004) Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension,

(2001) Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia,

(2001) Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension:evidence for a process of disordered angiogenesis,

(1998) Elastase and the pathobiology of unexplained pulmonary hypertension,

(2000) Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor,

(2000) Elastase and matrix metalloproteinase inhibitors induce regression,and tenascin-C antisense prevents progression,of vascular disease,